You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
11 July 2024
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
3 July 2024
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
24 June 2024
CureVac Announces Voting Results of General Meeting
28 May 2024
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
23 May 2024
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update